Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose citalopram effects on emotion processing in female borderline personality disorder patients (fMRI study)
2018-001212-30Phase 2Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in borderline personality disorder (BPD) comparing Citalopram with Placebo (2 arms). Primary endpoint: Amygdala and related brain-region BOLD response amplitude in OASIS paradigm. Started Jul 2018; status: completed.
02
Drugs
citalopram
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on 2018-001212-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001212-30.